Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Person › Details

Judith Gréciet (BioAlliance Pharma S.A.)

Gréciet, Judith (BioAlliance Pharma 201306 CEO + France Biotech 201508 Board Member)

 

Organisations Organisation BioAlliance Pharma S.A.
  Today Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO)
  Group Onxeo (Group)
  Former/major organisation France Biotech
Products Product Livatag®
  Product 2 Validive®
Document Source BioAlliance Pharma S.A.. (6/28/13). "Press Release: BioAlliance Pharma Launches a Capital Increase of €8 Million with Maintenance of Preferential Subscription Rights to Accelerate the Development of the Two Major Orphan Products (Livatag and Validive) [N
     

   
Record changed: 2018-08-03

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px


More documents for Judith Gréciet


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top